Pre-order Enquiry
Request Free Sample
Global Bacillus Coagulans Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13841542 | Publishing Date : 13-Feb-2019 | No. of pages : 119
Request Sample
Request Customization
Check Discounts
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
Scope of the Report:
The classification of Bacillus Coagulans includes Below 100 B, 100-200 B and Above 200 B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2016 is about 47%.
Bacillus Coagulans is widely used in Drugs, Food, Beverage and Supplement Products. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2016 is 37.5%. The trend of Supplement Products is increasing.
North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Bacillus Coagulans is expected to grow at a CAGR of roughly 8.1% over the next five years, will reach 29 million US$ in 2024, from 18 million US$ in 2019, according to a new study.
This report focuses on the Bacillus Coagulans in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ganeden
Sabinsa
Mitsubishi
Nebraska Cultures
Synbiotech
Syngen Biotech
Sanzyme
Microbax
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Below 100 B
100-200 B
Above 200 B
Market Segment by Applications, can be divided into
Drugs
Food
Beverage
Supplement Products
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bacillus Coagulans product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bacillus Coagulans, with price, sales, revenue and global market share of Bacillus Coagulans in 2017 and 2018.
Chapter 3, the Bacillus Coagulans competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacillus Coagulans breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Bacillus Coagulans market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Bacillus Coagulans sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The classification of Bacillus Coagulans includes Below 100 B, 100-200 B and Above 200 B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2016 is about 47%.
Bacillus Coagulans is widely used in Drugs, Food, Beverage and Supplement Products. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2016 is 37.5%. The trend of Supplement Products is increasing.
North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Bacillus Coagulans is expected to grow at a CAGR of roughly 8.1% over the next five years, will reach 29 million US$ in 2024, from 18 million US$ in 2019, according to a new study.
This report focuses on the Bacillus Coagulans in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ganeden
Sabinsa
Mitsubishi
Nebraska Cultures
Synbiotech
Syngen Biotech
Sanzyme
Microbax
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Below 100 B
100-200 B
Above 200 B
Market Segment by Applications, can be divided into
Drugs
Food
Beverage
Supplement Products
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bacillus Coagulans product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bacillus Coagulans, with price, sales, revenue and global market share of Bacillus Coagulans in 2017 and 2018.
Chapter 3, the Bacillus Coagulans competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacillus Coagulans breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Bacillus Coagulans market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Bacillus Coagulans sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
